Sanofi
SNYNF
$84.97
-$1.67-1.93%
OTC PK
| 12/31/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | ||
|---|---|---|---|---|---|
| Revenue | -- | 45.36B | 44.08B | 43.37B | |
| Total Other Revenue | -- | 3.32B | 3.27B | 3.38B | |
| Total Revenue | -- | 48.69B | 47.35B | 46.75B | |
| Cost of Revenue | -- | 13.94B | 13.74B | 13.92B | |
| Gross Profit | -- | 34.74B | 33.61B | 32.83B | |
| SG&A Expenses | -- | 10.10B | 9.85B | 9.80B | |
| Depreciation & Amortization | -- | 1.73B | 1.74B | 1.84B | |
| Other Operating Expenses | -- | 4.58B | 4.03B | 3.68B | |
| Total Operating Expenses | -- | 38.63B | 37.25B | 37.05B | |
| Operating Income | -- | 10.06B | 10.10B | 9.70B | |
| Income Before Tax | -- | 8.50B | 8.28B | 7.15B | |
| Income Tax Expenses | -- | 1.63B | 1.67B | 1.27B | |
| Earnings from Continuing Operations | -- | 6.87K | 6.61K | 5.87K | |
| Earnings from Discontinued Operations | -- | 3.10B | 76.24M | 63.57M | |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | |
| Minority Interest in Earnings | -- | -69.78M | -69.42M | -61.43M | |
| Net Income | -- | 9.90B | 6.62B | 5.88B | |
| EBIT | -- | 10.06B | 10.10B | 9.70B | |
| EBITDA | -- | 13.71B | 13.74B | 13.80B | |
| EPS Basic | -- | 8.03 | 5.30 | 4.69 | |
| Normalized Basic EPS | -- | 1.01 | -- | -- | |
| EPS Diluted | -- | 8.03 | 5.29 | 4.68 | |
| Normalized Diluted EPS | -- | 1.01 | -- | -- | |
| Average Basic Shares Outstanding | -- | 4.96B | 4.99B | 5.00B | |
| Average Diluted Shares Outstanding | -- | 4.96B | 5.00B | 5.01B | |
| Dividend Per Share | -- | 4.18 | 4.18 | 4.18 | |
| Payout Ratio | -- | 54.71% | -- | -- | |